Hosted on MSN1mon
Therapeutic designer peptide to combat acute heart muscle weaknessWade. The peptide acts safely and therapeutically in clinically relevant preclinical models of heart failure In their work, the two teams developed the basic structure of the new peptide ...
Diastolic heart failure is common in the elderly, particularly women. Previous studies on the value of brain natriuretic peptide in diastolic dysfunction have been largely limited to male subjects.
TIME-CHF [45] was designed to evaluate an NT-proBNP ... Therefore, the correlation between prognosis and a reduction in natriuretic peptide concentration might not be as strong as previously ...
Nesiritide is a recombinant form of B-type natriuretic peptide and is used for the treatment of acute decompensated heart failure. Nesiritide has potent vasodilatory properties and reduces ...
CHF 40.8 million, +7.5%), among other things thanks to higher sales of peptides for use in diagnostics. Bachem began construction of the world's most advanced production plant for large volumes of ...
Heart failure affects about 900,000 people in the UK. It happens when the heart becomes damaged, for example after a heart attack, and cannot pump blood around the body properly. B-type natriuretic ...
Generic drugmaker Granules India is foraying into the peptide segment and contract development and manufacturing organisation (CDMO) business with a ₹192.5 crore (CHF 20 million) acquisition of ...
Hosted on MSN27d
Granules India enters the high growing peptide segmentHyderabad-based Granules India has signed an agreement to acquire Senn Chemicals AG, a Swiss-based CDMO specializing in peptides, for CHF 20 million (approx. Rs 192 crore). Senn develops and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results